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Objectives. This study was designed to determine the preproce- 
dural risk factors for major complications (emergent coronary 
bypass surgery, myocardial infarction or death) of coronary 
angioplasty and to derive and validate a simplified index that 
predicts patients' a priori risk of complications. 
Background. Previous studies of risk factors for complications 
after coronary angioplasty may not be generalizable to current, 
broad-based angioplasty practice. Furthermore, to our knowledge 
a clinically useful predictive index has not been derived and 
independently validated. 
Methods. From data collected prospectively for the Registry of 
the Society for Cardiac Angiography and Interventions for 1992, 
multivariable logistic regression was used to determine which 
variables were independently associated with complications in 
10,622 first angioplasty procedures. Stepwise regression and 
receiver operating characteristic curves then were used in this 
registry to develop a predictive index for complications that was 
validated using 5,250 first angioplasty procedures in the 1993 
registry. 
Results. Predictors of major complications were multivessel 
disease, unstable angina, recent myocardial infarction, type C 
lesion or left main angioplasty, shock, age, geographic region and 
absence of previous coronary bypass surgery. The derived predic- 
tive index consisted of the first six of these variables plus aortic 
valve disease and classified patients into four risk groups: low 
(1.3% complications), moderate (2.8%), high (12.7%) and very 
high (29.7%) risk. This index demonstrated consistent reliability 
and discriminatory ability when applied to the 1993 data. 
Conclusions. Predictors of major complications identified in 
selected populations also apply currently in broad-based practice. 
From these variables, a predictive index can stratify patients into 
risk groups before angioplasty, thus aiding in risk assessment, 
resource allocation and risk adjustment. 
(J Am CoU Cardiol 1995;26:931-8) 
Despite improvement in success rates of percutaneous 
transluminal coronary angioplasty, the procedure is still 
associated with major complications, including acute myo- 
cardial infarction, abrupt vessel closure requiring emergent 
coronary artery bypass urgery and death. Current informa- 
tion on the risk of major complications and risk factors for 
these complications i derived mostly from studies of coro- 
nary angioplasty practice from almost a decade ago at single 
institutions or multiple high volume academic enters (1-4). 
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To our knowledge, the generalizability of these results to 
current, broad-based coronary angioplasty practice has not 
been thoroughly examined. 
Of equal importance, webelieve that no study to date has 
integrated both clinical and angiographic variables into a 
comprehensive predictive index that can be easily applied to 
estimate the risk of complications in patients undergoing 
coronary angioplasty and then validated this index in a sepa- 
rate patient population. Quantification of risk is important to 
patients, to clinicians who refer patients for coronary angio- 
plasty and to interventional cardiologists and angioplasty l b- 
oratories that want to compare their results with each other 
and with those predicted by the clinical characteristics of the 
patients they treat. 
Therefore, the goals of the current study were to 1) deter- 
mine the risk factors that are independently associated with
major complications after coronary angioplasty in current 
practice; 2) develop a clinical predictive index that can be 
easily applied to stratify patients into risk groups for major 
complications; and 3) validate this predictive index in a sepa- 
rate patient population. 
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Methods  
Data base and patient population. The Registry of the 
Society for Cardiac Angiography and Interventions, estab- 
lished in 1979, is a voluntary, prospective, multicenter, data 
collection instrument allowing individual l boratories and op- 
erators to track their activity. Details of the data collection 
techniques have been previously reported (5-7). There were 42 
centers participating in each of this study's registries 11992 and 
1993), with 34 of the same centers contributing data to both. 
Thirty three (78.6%) laboratories contributing to the 1992 
registry and 32 (76.2%) laboratories contributing to the 1993 
registry were from community-based hospitals (neither affili- 
ated with a university nor possessing a training program). 
Clinical characteristics of the patients are entered by support 
personnel in each laboratory before each patient's procedure, 
and all in-laboratory outcomes and all in-hospital deaths are 
recorded after the procedure. Only patients undergoing a first 
coronary angioplasty were included in the analysis. An inde- 
pendent audit of 18 participating laboratories was performed 
to confirm data accuracy. 
Data were collected for the clinical variables shown in 
Table 1. Complete data for all variables other than "multives- 
sel disease" were available for 97f~ of patients in the 1992 
registry and for 99% of patients in the 1993 registry. Complete 
data on stenoses incoronary vessels other than those subjected 
to angioplasty were recorded in separate diagnostic atheter- 
ization data bases, but, because of an inability to link patient 
records between these data bases and the angioplasty data 
bases, this nformation was not available for all patients in the 
present study. 
Outcome. The outcome of interest for the present study 
was major complications, defined as one or more of the 
following: 1) myocardial infarction, as evidenced by an increase 
in serum creatine kinase MB fraction levels to at least twice 
normal or development of new Q waves on the electrocardio- 
gram within 24 h of the procedure: 2)emergen O,bypass urgen' 
as a result of the procedure: or 3) death occurring any time 
during the hospital period. This composite outcome was 
chosen to allow comparison with earlier large studies (8-10) 
that identified risk factors for a similarly defined outcome. 
Patients with more than one of the criteria were counted only 
once in all analyses. 
Statistical analysis. Determination o[ risk factors fi)r com- 
plications. The incidence of each complication with associated 
exact 95% confidence intervals was determined. The univariate 
associations of variables with major complications were deter- 
mined using odds ratios and chi-square or Fisher exact tests for 
dichotomous variables and independent sample t tests for 
continuous variables. Multivariable logistic regression (11) 
then was performed to determine which preprocedural vari- 
ables in Table 1 were associated with complications after 
controlling for the confounding effects of all of the other 
variables. All of the statistical analyses were performed using 
the SPSS (version 6.0) and SAS (version 6.03) statistical 
Table 1. Baseline Characteristics of Patients Undergoing First 
Percutaneous Transluminal Coronary Angioplasty in 1992 and 1993 
Data Sets 
1992 1993 
Baseline Characteristic* [overall no. (%)] [overall no. (%)] 
All patients 10,622 (100) 10,030 (100) 
Mean (+SD) age (yr) 62.2 + 11.2 61.8 _+ 11.5 
Acute myocardial infarction 501 (4.7) 556 (5.5) 
within 24 h before 
coronary angioplasty 
Acute myocardial infarction 1,450113.7) 1,775 (17.7) 
within previous 
1-14 days 
Aortic valve disease 13 (0.1) 11 (0.1) 
Congestive heart failure 302 (2.8) 349 (3.5) 
Chronic renal insufficiency 172 (1.6) 170 (1.7) 
Dialysis 52 (0.5) 37 (0.4) 
Diabetes mellitus 1,558 (14.7) 1,581 (15.81 
During diagnostic procedure 1,881 117.7) 2,011 (20.0) 
Dye allergy 121 (1.2) 117 (1.2) 
Emergency procedure 873 (8.2) 896 (8.9) 
Geographic region 
Northeast 3,457 (32.5) 3,808 (38.0) 
South 2,464 (23.2) 2,328 (23.2) 
Midwest 3,190 (30.0) 2,454 (24.5) 
West 183 (1.7) 180 (1.8) 
Canada 1,328 (12.51 1,231 (12.3) 
South America 0 29 (0.3) 
Graft attempted 507 (4.8) 443 (4.4) 
Hypertension 3,606 (34.11) 3,728 (37.2) 
Laboratou' volume -<200 928 (8.7) 1,208 (12.0) 
cases/'yr 
LMCA attempted 53 (0.5) 40 (0.4) 
1,,,,,tie therapy during 635 (6.0) 723 (7.2) 
present illness 
Mitral valve disease 39 ([).4) 41 (0.4) 
Multivessel disease? 1.230 (28.7) 1,471 (28.0) 
No. of vessels attempted 
1 8,085 (76.1) 7,697 (76.7) 
2 1,977 (18.61 1,831 118.3) 
>3 559 (5.3) 502 (5.0) 
Previous bypass surgery. 1,1176110.2) 1,056 (10.5) 
Previous catheterization 7.772 (73.2) 7,285 (72.6) 
Previous valve surgery 23 (0.2) 31 (0.3) 
Shock 96 (0.9) 116 11.2) 
Unstable angina 3,333 (31.4) 3,482 (34.7) 
Women 3,412 (32.1) 3,109 (31.0) 
Worst lesion type attempted 
A 4,573 (43. I ) 4,119 (41.4) 
B 4,808 (45.3) 4,656 (46.4) 
C 1,2411 (11.7) 1,255 112.5) 
*See Appendix for definitions of baseline characteristics, lncludes only 
those with known multivessel disease status. LMCA = left main coronary artery. 
programs, and statistical significance was defined as a two- 
sided p value <0.05. 
Development ofmultivariable predictive index in 1992 deriva-
tion set. Because multivessel disease has been identified as an 
independent predictor of complications from coronary angio- 
plasty (1,4,10), the predictive index was derived in the 4,289 
patients in 1992 for whom this variable was known (the 
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derivation set). Only one patient had to be excluded because of 
missing data. Both forward and backward multivariable step- 
wise regression were used with increasingly strict entry and exit 
criteria to determine the most parsimonious et of clinical 
variables needed to predict major complications. The "final" 
model contained only those variables that added significant 
discriminatory ability to the model, as assessed by the area 
under the receiver operating characteristic curve (12-14). The 
reliability (the concordance between predicted and observed 
outcomes) of this model was assessed using the Hosmer- 
Lemeshow statistic (15) and a graphical plot of the observed 
proportion of major complications as a function of the mean 
predicted probability of complications within each quartile of 
predicted probability. 
To simplify the predictive index, ach variable in the final 
model was assigned a weight of 1, and each patient was 
assigned a score by adding up the number of risk factors 
present for that patient. Weighting each variable according to 
its regression coefficient, a more cumbersome process when 
used in practice, did not improve the discriminatory ability of 
the index. Individual risk scores were th n categorized into risk 
classes, using the likelihood ratio for each risk score (16). The 
final predictive index categorized risk classes such that the 
likelihood ratios for all scores in that class were similar. 
Validation of predictive index in 1993 validation set. The 
predictive index derived from the 1992 data set then was 
applied to those patients undergoing a first coronary angio- 
plasty in the 1993 data (the validation set) whose status of the 
variable "multivessel disease" was known. Complete informa- 
tion on all variables in the index was available for all patients 
in this data set. The actual incidence of complications was 
compared with the incidence predicted by the index. 
Resu l ts  
Patient population and outcomes. A total of 10,622 pa- 
tients with a first coronary angioplasty (4,289 with known 
multivessel disease status) constituted the data base for the 
1992 registry, and 10,030 (5,250 with known multivessel disease 
status) constituted the data base for the 1993 registry. Table 1 
shows the baseline characteristics of both of these populations. 
The two patient populations were similar with respect to most 
baseline characteristics. The data audit revealed that at least 
95% of procedures at each audited laboratory were entered 
into the data base. 
There were 240 major complications in 1992 and 202 major 
complications in 1993, representing risks of 2.3% (95% confi- 
dence interval [CI] 2.0% to 2.5%) and 2.0% (95% CI 1.7% to 
2.3%), respectively. In 1992, 45 procedures resulted in death 
(incidence 0.4%, 95% CI 0.3% to 0.6%), 159 in emergent 
bypass surgery (1.5%, 95% CI 1.3% to 1.7%) and 66 in an 
acute myocardial infarction within 24 h of the procedure 
(0.6%, 95% CI 0.5% to 0.8%). In 1993, the risks of death, 
emergent bypass surgery and acute myocardial infarction were 
0.5% (95% CI 0.4% to 0.6%), 1.2% (95% CI 1.0% to 1.5%) 
and 0.5% (95% CI 0.4% to (I.6%), respectively. 
Predictors of major complications in 1992 registry. 
Significant univariate and multivariable predictors of major 
complications are shown in Table 2. The risk of a complication 
increased by 15% for each increase in age of 10 years. 
Multivariable analysis in thesubset of patients with informa- 
tion on the presence or absence of multivessel disease revealed 
that multivessel disease was a significant predictor of major 
complications in this subgroup (odds ratio [OR] 1.59, p = 
0.038). However, controlling for this variable in this subset of 
patients did not affect he predictive ability of any of the other 
variables presented in Table 2 (i.e., their odds ratios were 
unchanged). When the multivariable analysis was limited to 
patients who had only single-vessel native artery coronary 
angioplasty (i.e., those patients in whom a complication c uld 
be attributed specifically to the vessel undergoing angioplasty), 
lesion location was predictive of major complications only for 
left main coronary angioplasty (OR 5.61, p < 0.001). Previous 
bypass surgery appeared protective against major complica- 
tions. Although those patients with previous bypass surgery 
were no more likely than those without previous bypass surgery 
to die (OR 0.9, p = 1.0) or to have an acute myocardial 
infarction (OR 1.3, p = 0.43), there was a trend toward a 
decreased risk of emergent bypass surgery in patients with 
previous bypass surgery (OR 0.48, p = 0.10). 
Development of predictive index in 1992 data set. The 
seven variables included in the predictive index were aortic 
valve disease, left main coronary angioplasty, shock, acute 
myocardial infarction within 24 h before coronary angioplasty, 
type C lesion coronary angioplasty, multivessel disease and 
unstable angina. Risk scores were classified into four risk 
classes: low (none of the above risk factors present), moderate 
(one or two risk factors present), high (three risk factors) and 
very high risk (more than three risk factors). The incidence of 
major complications increased markedly with increasing risk 
class of the predictive index (Table 3, chi-square test for linear 
trend p < 0.00001). 
The prevalence of major complications as a function of the 
predicted probability of complications for each quartile of 
predicted risk is shown for the final model in Figure 1. The 
area under the receiver operating characteristic curve for the 
predictive index (0.71) (Fig. 2) was statistically indistinguish- 
able from the area under the curve for the "complete" model 
containing all variables in Table 1 (p - 0.15). Thus, the 
discriminatory ability was unaffected by limiting the variables 
in the index to those previously indicated. 
Validation of predictive index in 1993 validation set. Ap- 
plying the predictive index to the 1993 validation set revealed 
a marked increase in risk with increasing scores on th  index 
(Table 3) (chi-square test for linear trend, p < 0.00001). The 
area under the receiver operating characteristic curve, albeit 
smaller (0.65), was not statistically significantly different (p = 
0.49) from that under the receiver operating characteristic 
curve derived from the 1992 data set (Fig. 2). The reliability of 
the index in this data set was also extremely good (Fig. 1). 
934 K1MMEL ET AL JACC Vol. 26, No. 4 
PREDICTING ANGIOPLASTY COMPLICATIONS October 1995:931-8 
Table 2. Associations of Clinical Variables With Major Complications in 1992 Data Set 
Univariate OR Multivariable OR 
Variable* (95% CI) (95% CI)t 
Age (continuous) 2.16 ((I.72, 3.60)~§ 1.01 (1.00, 1.03)[I 
AMI within 24 h before coronaD' angioplasty 4.44 13.14, 6.30)¶ 2.20 (1.25, 3.86)§ 
AMI within previous 1-14 days 0.70 (0.46, 1.07) 0.73 (0.46, 1.16) 
Aortic valve disease 7.92 (1.75, 35.9)11 5.16 (0.94, 28.3) 
Congestive heart failure 2.01 (1.13, 3.55)11 1.29 (0.68, 2.45) 
During diagnostic procedure 2.15 (1.64, 2.85)¶ 1.43 (0.99, 2.06) 
Emergency procedure 2.82 (2.03, 3.91)¶ 1.20 (0.73, 1.98) 
Geographic region ¶ § 
Northeast (referent) 1.0 1.0 
South 1.7011.19, 2.44)§ 1.51 (1.03, 2.21)11 
Midwest 1.57 (1.1 I, 2.22) 1 1.42 (0.97, 2.06) 
West 4.34 (2.28, 8.26)¶ 4.64 (1.99, 10.81¶ 
Canada 1.33 (0.84, 2.11) 1.33 (0.82, 2.14) 
Laboratory volume <2110 cases/yr 1.51 (1.02, 2.22111 1.09 (0.64, 1.88) 
LMCA attempted 6.75 (3.02, 15.11¶ 5.9l (2.36, 14.8)¶ 
Multivessel disease# 2.23 (1.64, 3.05)¶ 1.59 (1.03, 2.45)11 
Mitral valve disease 5.01 (1.77. 14.2)1I 2.92 (0.89, 9.51) 
Previous bypass surgery. 0.90 (0.58, 1.40) 0.50 (0.25, 0.98)11 
Previous catheterization //.74 (0.56.0.97)11 1. l I (0.79, 1.56) 
Previous valve surgery 4.15 (0.97, 17.8) 4.28 (0.96, 19.1) 
Shock 11.5 16.41, 20.5)¶ 4.11 12.13, 7.92)¶ 
Unstable angina 1.69 ( 1.31, 2.19)¶ 1.54 (1.17, 2.03)§ 
Women 1.12 (0.86, 1.47) 1.00 (0.75, 1.34) 
Worst lesion type attempted ¶ II 
A (referent) 1.11 1.0 
B 1.10 (0.83, 1.47) 1.01 (0.75, 1.37) 
C 2.03 11.42, .90)¶ 1.67 11.13, 2.46)§ 
*See Appendix for definitions of variables, tAll variables in Table 1 except multivessel disease included in multi- 
variable model. :[:Difference in mean age between those with and those without major complications. §p < 0.01. lip < 0.05. 
¶p < 0.0111. #For subset of patients with known multive~sel disease status; multivariable odds ratio (OR) adjusted for all 
variables in Table 1. CI = confidence interval. 
Discuss ion  
The Registry of the Society for Cardiac Angiography and 
Interventions currently represents the largest reported multi- 
center data base that includes prospectively collected data on 
many important clinical variables previously described as risk 
factors for complications from coronary angioplasty. Unlike 
most other registries and previous studies of coronary angio- 
plasty complications, the Registry of the Society for Cardiac 
Angiography and Interventions is geographically heteroge- 
neous, includes all patients undergoing coronary angioplasty in 
participating laboratories and represents results from contem- 
porary experience among both academic and community- 
based hospitals. Thus, these results should be more generaliz- 
able to current coronary angioplasty practice than those arising 
from older data bases, from single-center studies and from 
randomized trials. 
Risks of major complications. The overall risk of compli- 
cations in both the 1992 and 1993 registries was low, reflecting 
the decreasing complication risk of coronary angioplasty over 
the past decade (17). These lower risks of complications are 
Table 3. Likelihood Ratios and Complication Rates for Each Risk Class of Predictive Index 
1992 Derivation Set* 1993 Validation Sett 
Risk Class Complication Complication 
(no. of risk factors) LR Rate (n) LR Rate (n) 
I (0) 0.47 1.3c:;- ( 1,6791 0.56 1.3% (2,054) 
I1 (I-2) 1.01 2.8c,; 12,430t 1.13 2.5% (2,970) 
Ill (3) 5.119 12.7% (142) 2.50 5.4% (1841 
IV (>3) 14.811 29.7% (37) 8.70 16.7% (42) 
*Area under receiver operating characteristic curve 0.71. tArea under receiver operating characteristic curve 0.65. 
LR = likelihood ratio', n - number of patients in risk class. 
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Figure l. Reliability of the predictive index for estimating the likeli- 
hood of major complications when applied to both the 1992 and the 
1993 data sets. The observed proportion of patients with major 
complications is hown as a function of the mean predicted probability 
of major complications forquartiles ofpredicted risk as derived from 
the predictive index. Solid line = perfect reliability of the data and is 
shown only for reference; diamonds = 1992 data set (Hosmer- 
Lemeshow goodness of fit, p : 0.869); circles = 1993 data set 
(Hosmer-Lemeshow goodness offit, p = 0.894). 
consistent with recent data (8) and may reflect improvements 
in technology and increasing operator experience despite an 
increase in higher risk procedures (1,17,18). Because acute 
myocardial infarctions occurring >24 h after coronary angio- 
plasty (the minority of coronary angioplasty-related AMIs) 
(19) were not identified in the present study, the incidence of 
this complication is probably somewhat underestimated. 
Figure 2. Receiver operating characteristic curves comparing the
discriminatory ability of the predictive index in the 1992 derivation set 
from which the index was derived (area under the curve 0.71) and the 
1993 validation set (area under the curve 0.65). Forty-five degree line = an 
area of 0.50 (discrimination no better than random guessing). Curves are 
derived from the index using 1 point/risk factor. 
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Predictors of complications. Most of the predictors of 
major complications identified in this registry have been de- 
scribed previously (3,4,8-10,18,20-25), thus extending their 
applicability to more current and more diverse coronary an- 
gioplasty practice. However, a few risk factors identified in the 
present study have not previously been described. Aortic valve 
disease, a strong predictor of major complications in both data 
sets, has not been described previously as a risk factor for 
complications ofcoronary angioplasty. A previous st dy (26) of 
diagnostic atheterizations identified aortic valve disease asa 
predictor of complications, although no mechanism was eluci- 
dated. Previous bypass surgery appears to be protective against 
major complications because of the decreased likelihood of 
referring a patient with previous bypass surgery fo  repeat 
operation. Finally, there appears to be geographic variability 
with an increase in complications in the South and West, even 
after accounting for differences in patient risk. Geographic 
variability in practice patterns and outcomes has been demon- 
strated in a data base of privately insured patients <65 years 
old (27). Despite the suggestions of this and previous studies, 
the findings in the current study deserve cautious interpreta- 
tion and further exploration, given the self-selected nature of 
laboratories in the registry and the small number of laborato- 
ries representing the western region. 
Value of predictive index. The predictive index derived in 
the present study represents an easily applied tool that uses 
readily available clinical variables to stratify patients into risk 
groups. Most previous studies have presented the reader with 
only a series of odds ratios or regression coefficients derived 
from explanatory analyses that utilize variables based on their 
individual p values. To our knowledge, no attempt has been 
made to determine the most parsimonious et of clinical 
variables needed to predict accurately the risk of complica- 
tions, to simplify the results into a predictive index and then to 
validate this index in a separate patient population. Although 
an index has been developed to predict hemodynamic effects of 
balloon inflation (28), this index is not useful in predicting risk 
of clinically important complications before angioplasty. Other 
studies (29) have used angiographic criteria only and were 
limited by small sample sizes. 
The validation of a predictive index in a separate patient 
population is a crucial but infrequently performed step in 
developing a useful and generalizable model (30,31). Because 
only first angioplasty procedures were analyzed, the validation 
population i  the present study represents a truly independent 
sample of patients, the preferable sample in which to validate 
a predictive index (30). As expected (32), the index fared 
slightly more poorly in the validation set compared with the 
derivation set. However, the lack of statistically significant 
differences in receiver operating characteristic areas and the 
consistent reliability of the index illustrate its generalizability in 
a different patient population. 
The predictive index has several important uses: 
1. It may be useful in discussing risk with patients who must 
consent to undergo coronary ngioplasty. Rather than present- 
ing patients with the average risk of complications for all 
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patients undergoing coronary angioplasty, a physician can tell 
patients which risk class they are in and the approximate 
probability of having a major complication, thus improving the 
process of informed consent. 
2. The index can be useful in identifying which patients 
should receive new and expensive adjuvant herapies. As the 
present study shows, most patients undergoing balloon angio- 
plasty are at low risk of complications. It is the small group of 
higher risk patients that should initially be targeted to receive 
modifications of or adjuvant reatments o conventional bal- 
loon angioplasty. 
3. Interventional cardiologists and individual aboratories 
can compare their overall results with the probability of 
complications predicted by applying the index to their partic- 
ular patient population. Because the index predicts only prob- 
abilities of complications and not whether an individual patient 
will or will not have a complication, this risk adjustment should 
not be performed on an individual patient basis. Rather, an 
overall risk-adjusted probability of complications can be cal- 
culated for physicians or laboratories on the basis of the 
distribution of their patients in each risk class. For instance, a
physician or laboratory that treats mostly high risk patients 
would be expected to have a complication rate closer to 12.7% 
(the high risk probability) than 1.3% (the low risk probability). 
Potential limitations of the study. Several possible limita- 
tions of this study must be considered in interpreting the 
results. 
1. The discriminatory ability of the predictive index is only 
moderate. Thus, the index can predict only the probability of a 
complication, not what will happen to an individual patient. 
This is to be expected when trying to predict an outcome that 
is as rare as major complications after coronary angioplasty 
(33). It is possible that information on other previously de- 
scribed risk factors that are not available in these data bases, 
such as ejection fraction (8), body surface area (18) or detailed 
characterization f coronary lesion morphology (29), would 
add discriminatory ability to the predictive index. Nonetheless, 
the broad range of available variables in the present study 
provides a fairly complete characterization f patients' clinical 
presentations. Despite its limited use in individual patients the 
index can be useful in assigning patients to risk categories and 
in risk adjustment on a group basis, as previously discussed. Of 
note, primary coronary angioplasty for acute myocardial in- 
farction could not be analyzed as a separate variable in these 
data bases but is included (to an unknown degree) in a fraction 
of the patients undergoing coronary angioplasty within 24 h of 
an acute myocardial infarction. 
2. As in most previous registries, verification of risk factors 
and routine screening for post-coronary angioplasty acute 
myocardial infarction were not routinely performed. However, 
verification of data entry was performed in a sample of 
laboratories, and it is unlikely that clinically apparent acute 
myocardial infarctions caused by abrupt vessel closure occur- 
ring within 24 h of the procedure were missed. It is possible 
that recording of preprocedural clinical variables was biased by 
knowledge of the outcome of the coronary angioplasty. How- 
ever, laboratories were instructed to collect all clinical vari- 
ables before the procedure, thus minimizing (although not 
eliminating) this possible bias. If there was significant misclas- 
sification in this study, it was most likely random, thus under- 
estimating the true association between a risk factor and the 
outcome (34). 
3. Because the predictive index was derived from a popu- 
lation of patients all of whom had coronary angioplasty, the 
utility of the index in deciding who should or should not have 
coronary angioplasty is unproved. That is, it is not known what 
would have happened to high risk patients had they undergone 
bypass urgery or intensive medical therapy rather than coro- 
nary angioplasty. 
Conclusions. The incidence of major complications and 
death from coronary angioplasty is low in this large registry 
representing current and varied practice, consistent with pre- 
vious studies that suggest a decrease in complications from 
coronary angioplasty over the past decade. Also, many previ- 
ously identified risk factors for major complications are gen- 
eralizable to the current broad-based angioplasty practice. 
The predictive index derived and validated in the present 
study represents an easily applied tool using readily available 
clinical variables that can be employed to stratify patients into 
risk groups before coronary angioplasty. The index should be 
most useful in providing patients with more accurate risk 
assessment before obtaining consent for coronary angioplasty, 
in allocating adjunctive therapies to high risk angioplasty 
procedures and in properly interpreting the rate of complica- 
tions of intep~entionalists and laboratories on the basis of the 
clinical characteristics of the patients whom they treat. 
We thank Ronald Krone, MD for helpful comments during the preparation f 
the manuscript and John Batzel for assistance with document preparation. 
Appendix 
Glossary o f  Preprocedural Variables (Tables 1 and 2) 
Aortic valve disease: any aortic valve regurgitation or stenosis 
Acute myocardial infarction within 24 h before coronary angi pl sty 
Acute myocardial infarction within I to 14days before coronary 
angioplasty 
Congestive heart failure: includes but not limited to pulmonary 
edema, jugular venous distention, hepatomegaly, gallop 
rhythm, peripheral or presacral edema 
Chronic renal insufficiency: serum creatinine >2.0 mg/dl 
Dialysis: patient undergoing hemodialysis or peritoneal dialysis 
Diabetes mellitus: receiving either oral hypoglycemic agents or 
insulin 
During diagnostic procedure: coronary angioplasty performed dur- 
ing a diagnostic catheterization procedure 
Dye allergy: previous allergic reaction to contrast agent 
Emergency procedure: patient taken to laboratory  other than 
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regularly scheduled hours or out of sequence so that sched- 
uled patients are delayed 
Gender 
Geographic region (same divisions as in reference 27) 
Northeast: Connecticut, Massachusetts, New Jersey, New 
York, Pennsylvania 
South: District of Columbia, Florida, Georgia, Maryland, 
North Carolina, South Carolina, Virginia, Mississippi, 
Tennessee, Oklahoma, Texas 
Midwest: Illinois, Ohio, Indiana, Michigan, Wisconsin, Ne- 
braska, Missouri 
West: Arizona, Colorado, Montana, California, Oregon, Ha- 
waii 
Canada: British Columbia, Nova Scotia 
South America: Buenos Aires 
Graft attempted: any coronary bypass graft (vein or artery) at- 
tempted uring procedure 
Hypertension: diastolic pressures --_IlR} mm Hg or patient aking 
antihypertensive m dication 
Laboratory volume: number of balloon angioplasty procedures 
performed in each laboratory/year (including repeat proce- 
dures), dichotomized into >200 or <200 procedures/year 
(based on minimal laboratory volume of 200 cases/year 
recommended by the American Heart Association and 
American College of Cardiology,) (35) 
Left main attempted: left main coronary artery attempted uring 
procedure 
Lytic therapy during present illness: ytic therapy before coronary' 
angioplasty 
Mitral valve disease: any mitral valve regurgitation or stenosis 
Multivessel disease: two or more lesions in two or more coronary 
distributions, each with ->70% stenosis 
Number of vessels attempted: number of vessels attempted uring 
single procedure 
Previous bypass surgery: any previous coronary artery bypass urgery 
Previous catheterization: any previous catheterization 
Previous valve surgery: any previous valve replacement or repair 
Shock: unsupported systolic blood pressure <80 mm Hg with a 
heart rate >95 beats/min, peripheral signs of vascular col- 
lapse; includes patients on ventilator or intraaortic balloon 
pump or taking high doses of vasopressor agents; or patients 
receiving cardiopulmonary resuscitation. 
Unstable angina: crescendo angina despite medical therapy, postin- 
farction angina or admitting diagnosis of unstable angina 
Worst lesion type attempted: worst lesion type (American College of 
Cardiology/American Heart Association Task Force classifi- 
cation of lesion type) attempted uring procedure 
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